Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna and sponsored by the University of Oxford, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer. 👏
www.cancer.ox.ac.uk/news/first-t...
www.cancer.ox.ac.uk
Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna, sponsored by the University of Oxford and run by the University's Oncology Clinical Trials Office with support from Oxford Cancer, has...
